Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Methylcholanthrene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00899
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Methylcholanthrene up-regulates the expression of DME UGT1A8 |
[1] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Tobacco smoke pollution |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Tobacco smoke pollution up-regulates the expression of DME UGT1A8 |
[2] |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Amentoflavone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01195
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT1A8 |
[3] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Doxycycline |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00199
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Doxycycline up-regulates the expression of DME UGT1A8 |
[4] |
Vorinostat |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00079
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Vorinostat inhibits the expression of DME UGT1A8 |
[5] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the expression of DME UGT1A8 |
[6] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Hymecromone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00555
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1/2 |
DME Modulation |
Hymecromone induces the drug-metabolizing activity of DME UGT1A8 |
[7] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
(+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
(+)-JQ1 inhibits the expression of DME UGT1A8 |
[8] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Beta-naphthoflavone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01220
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Beta-naphthoflavone up-regulates the expression of DME UGT1A8 |
[9], [10] |
Pregnenolone carbonitrile |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01437
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Pregnenolone carbonitrile up-regulates the expression of DME UGT1A8 |
[11] |
|
|
|
|
|
|